Literature DB >> 31842525

Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey.

Kyung-Ah Kim1, June Sung Lee1.   

Abstract

Background/Aims: This study aimed to investigate the epidemiology of hepatitis C virus (HCV) infection in the Korean general population and the awareness and treatment status of HCV infection among anti-HCV-positive persons.
Methods: We used data from the Korea National Health and Nutrition Examination Survey (KNHNES) collected between 2012 and 2016. All the participants aged ≥10 years in the KNHNES were tested for the anti-HCV antibody. Anti-HCV-positive persons were tested for HCV RNA and assessed for their awareness and treatment experience regarding HCV infection.
Results: The prevalence of anti-HCV was 0.66% (95% confidence interval, 0.56% to 0.78%) among Koreans aged ≥10 years, representing an estimated 278,819 anti-HCV-positive persons, and 0.71% (95% confidence interval, 0.60% to 0.84%) among Koreans aged ≥20 years. The prevalence of anti-HCV increased with age and had significant geographic variation. The positive rate of HCV RNA in anti-HCV-positive persons was 33.5% and increased with age. The rate of HCV infection awareness was 15.2% (35/250) among anti-HCV-positive persons and 30.5% (18/59) among HCV RNA-positive persons. Among the participants, 13.5% of HCV RNA-positive persons had been treated for HCV infection. Conclusions: The prevalence of anti-HCV among Koreans aged ≥20 years was 0.71%; one-third of anti-HCV-positive persons tested HCV RNA-positive. The awareness and treatment rates of HCV infection were low among HCV-infected persons. Therefore, active measures should be taken to diagnose and treat persons unaware of HCV infection.

Entities:  

Keywords:  Awareness; Hepatitis C; Population surveillance; Prevalence; Therapeutics

Year:  2019        PMID: 31842525     DOI: 10.5009/gnl19272

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  5 in total

Review 1.  Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region.

Authors:  Jenny Iversen; Handan Wand; Po-Lin Chan; Linh-Vi Le; Lisa Maher
Journal:  Viruses       Date:  2022-07-15       Impact factor: 5.818

2.  Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea.

Authors:  Dae Hyun Lim; Jae Yoon Jeong; Seongwoo Nam; Jongkyoung Choi; Hyeok Choon Kwon; Yong Bum Yoon; Yeonjae Kim; BumSik Chin
Journal:  J Korean Med Sci       Date:  2021-11-29       Impact factor: 2.153

3.  Spatial epidemiologic analysis of the liver cancer and gallbladder cancer incidence and its determinants in South Korea.

Authors:  Jieun Jang; Dae-Sung Yoo; Byung Chul Chun
Journal:  BMC Public Health       Date:  2021-11-14       Impact factor: 3.295

4.  Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID.

Authors:  Kyung-Ah Kim; Gwang Hyun Choi; Eun Sun Jang; Young Seok Kim; Youn Jae Lee; In Hee Kim; Sung Bum Cho; Moran Ki; Hwa Young Choi; Dahye Paik; Sook-Hyang Jeong
Journal:  Epidemiol Health       Date:  2021-10-06

Review 5.  Cost-effectiveness of chronic hepatitis C screening and treatment.

Authors:  Hye Won Lee; Hankil Lee; Beom Kyung Kim; Young Chang; Jae Young Jang; Do Young Kim
Journal:  Clin Mol Hepatol       Date:  2021-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.